Using oscillometry and FeNO to improve primary care diagnosis of asthma and COPD
Official title: A Study to Evaluate the Accuracy of Primary Care Diagnosis Using Oscillometry and Fractional Exhaled Nitric Oxide for Asthma and COPD Versus Specialist Diagnosis in Patients With Suspected Asthma or COPD
Run by AstraZeneca · NCT07245576 · Data updated 2026-11-12
This study will test whether oscillometry and FeNO measurements help primary care doctors more accurately diagnose asthma and COPD in adults with suspected symptoms.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | AstraZeneca Industry-sponsored |
| Locations | 12 sites (Buenos Aires and 11 other locations) |
| Status | Recruiting |
| Started | December 26, 2025 |
| Main results expected | April 30, 2027 |
| Study ends | April 30, 2027 |
| Registry record updated | October 13, 2026 |
| Trial ID | NCT07245576 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with new respiratory symptoms who do not already have a confirmed diagnosis of asthma or COPD—specifically those ≥18 for suspected asthma and ≥40 for suspected COPD—are the intended participants.
✕Probably not a fit
People with an existing diagnosis of asthma or COPD, recent use of inhaled or oral corticosteroids, or other diseases that affect lung function are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with suspected asthma (≥18 years) or suspected COPD (≥40 years) who have no prior diagnosis and meet exclusion criteria will undergo oscillometry, FeNO testing, and standard spirometry where feasible. Test results obtained in the primary care/research sites will be compared with specialist clinical diagnosis and spirometry-based criteria to measure diagnostic accuracy. The observational protocol collects diagnostic data at sites in Buenos Aires, Mendoza, and Alexandria without altering routine clinical management. Patients with recent inhaled or oral corticosteroid use or other conditions that affect lung function are excluded to reduce confounding.
Why it matters
Potential benefit: If successful, using oscillometry and FeNO could enable faster and more accurate diagnosis of asthma and COPD in primary care, reducing delays and unnecessary referrals.
How similar studies have gone: FeNO has established utility for detecting eosinophilic airway inflammation and some prior studies suggest oscillometry is promising, but combining these tools as a primary-care diagnostic pathway remains relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients are eligible to be included in the study if all the following criteria apply and after providing written informed consent: Suspected asthma (asthma group) 1. Patients ≥ 18 years old or with legal age of consent in the jurisdiction in which the study is taking place, at the time of signing the ICF. 2. Patients presenting with symptoms of wheezing, cough, chest tightness, shortness of breath, but without a clinically confirmed diagnosis of asthma. Suspected COPD (COPD group) 1. Patients ≥ 40 years old at the time of signing the ICF. 2. Patients presenting with symptoms of dyspnea, chronic cough or sputum production, but without a clinically confirmed diagnosis of COPD. Exclusion Criteria: Patients are excluded from the study if any of the following criteria apply: 1. Prior diagnosis of COPD or asthma. 2. Use of ICS in the last 6 months or use of oral corticosteroids in the last 3 months. 3. Any diseases that influence lung function result such as lung cancer, pneumonia, active pulmonary tuberculosis, pulmonary embolism, and interstitial lung disease. 4. Any history of recent surgery that affects lung function results, including but not limited to thoracotomy surgery, pneumothorax surgery, and thoracic drainage. 5. Contraindication to spirometry or oscillometry test, or allergy to bronchodilator. 6. Currently pregnant or breast-feeding women. 7. If the investigator judges that the patient is unlikely to comply with study procedures, restrictions, and requirements.
Where it's running
-
Research Site
Buenos Aires, Argentina Recruiting -
Research Site
Medoza, Argentina Recruiting -
Research Site
Ho Chi Minh City, Vietnam Recruiting -
Research Site
Alexandria, Egypt Not yet recruiting -
Research Site
El Waili, Egypt Not yet recruiting -
Research Site
Monterrey, Mexico Not yet recruiting
Show 6 more locations
-
Research Site
Santiago de Quer Taro, Mexico Not yet recruiting -
Research Site
Riyadh, Saudi Arabia Not yet recruiting -
Research Site
Taichung, Taiwan Not yet recruiting -
Research Site
Taoyuan City, Taiwan Not yet recruiting -
Research Site
Dubai, United Arab Emirates Not yet recruiting -
Research Site
Hanoi, Vietnam Not yet recruiting
Study contacts
- Study coordinator: AstraZeneca Clinical Study Information Center
- Email: information.center@astrazeneca.com
- Phone: 1-877-240-9479
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Asthma and COPD among workers at Navanakorn Industrial Zone in Thailand
This project will test how common asthma and COPD are among adult workers at the Navanakorn Industrial Zone by asking about breathing symptoms and doing lung function (spirometry) tests.
-
Using smartphone technology to evaluate airway conditions
This study is testing if smartphone technology can help check lung health and spot breathing problems in both healthy people and those with asthma or COPD.
-
Identifying and treating undiagnosed asthma or COPD in Canadians
This study is trying to find Canadians who might have asthma or COPD without knowing it and see if getting diagnosed and treated early can improve their quality of life.
-
Understanding muscle loss in patients with chronic lung diseases
This study looks at how muscle loss affects people with chronic lung diseases like COPD and ILD to see how common it is and how it relates to their overall health.
-
Understanding immune profiles in healthy and diseased lungs
This study is trying to understand how the immune system works in healthy lungs compared to those with airway diseases like COPD and asthma by looking at samples from both groups.
-
Assessing diaphragm function in patients with respiratory diseases
This study is testing how well the diaphragm works in people with respiratory diseases to see if it affects their breathing difficulties and overall health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.